Research Support as Topic

• 

  Subject Areas on Research

  • 1995 Public Policy Plenary Symposium: "the crisis in clinical research". 
  • 21st century--Reproductive Medicine Network (RMN). 
  • A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability. 
  • A Roadmap for a New Academic Pathway for Global Radiation Oncology. 
  • A cooperative network of trained sites for the conduct of a complex clinical trial: a new concept in multicenter clinical research. 
  • A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design. 
  • A guide for success as a clinical investigator. 
  • A hub for bench-to-bedside pharmacogenomic-based research. 
  • A limited bibliography of the Federal Government-funded human radiation experiments. 
  • A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. 
  • A prescription for promoting social work research in a university hospital. 
  • A roadmap for academic health centers to establish good laboratory practice-compliant infrastructure. 
  • A rubric for improving the quality of online courses. 
  • A survey of past obstetrics and gynecology research fellows. 
  • ACCF/AHA consensus conference report on professionalism and ethics. 
  • Accountability in Patenting of Federally Funded Research 
  • American College of Radiology Imaging Network: new national cooperative group for conducting clinical trials of medical imaging technologies. 
  • American Heart Association National Research Awards. New programs for 1996. 
  • American Society of Pediatric Nephrology position paper on linking reimbursement to quality of care. 
  • American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy? 
  • An ENA state research committee: the Illinois experience. 
  • An interview with Barton Haynes. A new virtual center. Interview by Simon Noble. 
  • An investigation into nonscientist involvement in peer review: the National Institutes of Health example. 
  • Artful design: writing the proposal for research in the naturalist paradigm. 
  • Availability and Use of Shared Data From Cardiometabolic Clinical Trials. 
  • Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting? 
  • Building a Workforce for Skin Biology Research in the People's Republic of China. 
  • Building a platform for translational research in chronic noncommunicable diseases to address population health: lessons from NHLBI supported CRONICAS in Peru. 
  • Building the science for nursing education: vision or improbable dream. 
  • CTSAs and family medicine research--time to get connected. 
  • Canadian Task Force for Cardiovascular Science. A Joint Initiative of the Heart and Stroke Foundation of Canada and the Canadian Cardiovascular Society. 
  • Career outcomes of the graduates of the American Board of Internal Medicine Research Pathway, 1995-2007. 
  • Career progress in online and blended learning environments. 
  • Careers for clinician investigators. 
  • Challenges facing translational research organizations in China: a qualitative multiple case study. 
  • Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. 
  • Clinical nursing research: you can do it! 
  • Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme. 
  • Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database. 
  • Clinical-trial agreements between medical schools and industry. 
  • Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. 
  • Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop. 
  • Comparative effectiveness research in oncology: the need for clarity, transparency and vision. 
  • Compliance with results reporting at ClinicalTrials.gov. 
  • Conduct of multisite clinical studies by professional organizations. 
  • Conducting empirical research on informed consent: challenges and questions. 
  • Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents. 
  • Crafting a national agenda for nursing education research. 
  • Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. 
  • Debating the current status of research in family medicine. 
  • Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research. 
  • Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. 
  • Dissemination and commercialization of hematopoietic progenitor cell transplantation. 
  • Does Brussels listen? European health systems research in developing countries at the edge of extinction. 
  • Donors reject screening panel for malaria projects. 
  • Drug-company sponsorship and the Declaration of Helsinki. 
  • Effects of disclosing financial interests on participation in medical research: a randomized vignette trial. 
  • Emergency care research funding in the global health context: trends, priorities, and future directions. 
  • Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. 
  • Ethics of tobacco company funding. 
  • Ethnic and geographic diversity of stone disease. 
  • Factors influencing the participation of gastroenterologists and hepatologists in clinical research. 
  • Fostering creativity: how the Duke Graduate Medical Education Quasi-Endowment encourages innovation in GME. 
  • Fostering innovation in medicine and health care: what must academic health centers do? 
  • Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials. 
  • Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. 
  • Funding should come to those who wait. 
  • Gender differences in salary in a recent cohort of early-career physician-researchers. 
  • Gender, racial, and ethnic disclosure in NIH K-Award funded diabetes and obesity clinical trials. 
  • Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. 
  • Global operating theatre distribution and pulse oximetry supply: an estimation from reported data. 
  • Guidelines for international collaborative research. 
  • How to make nursing research work for you. 
  • Hyperbaric oxygen therapy and neurological disease. 
  • Identifying research needs for improving health care. 
  • Impact of Funding Source on Clinical Trial Results Including Cardiovascular Outcome Trials. 
  • Implementing the research budget. 
  • Incorporating research into thoracic surgery practice. 
  • Independent research by early investigators: an underutilized option. 
  • Industrial collaboration. 
  • Industrial research: a necessary evil or a blessing? Suggestions for avoiding pitfalls. 
  • Innovative strategic Canadian research training from TomorrOw's Research Cardiovascular Health Care Professionals (TORCH). 
  • Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI. 
  • Is Bayh-Dole Good for Developing Countries? Lessons from the U.S. Experience 
  • Issues in regulatory guidelines for data monitoring committees. 
  • Let's abolish the Office of Alternative Medicine of the National Institutes of Health. 
  • Making the case for laws that improve health: a framework for public health law research. 
  • Managing accrual in cooperative group clinical trials. 
  • Measuring contributions to the research mission of medical schools. 
  • Medicine. The need for a global HIV vaccine enterprise. 
  • Meeting the challenges facing clinical research: solutions proposed by leaders of medical specialty and clinical research societies. 
  • Mental health services system research: the National Institute of Mental Health program. 
  • Multidisciplinary Women's health research: the national centers of excellence in women's health. 
  • NIH and cost-effectiveness studies for imaging. 
  • NIH funding trajectories and their correlations with US health dynamics from 1950 to 2004. 
  • Net economic costs of dementia in Canada. 
  • Nonscientist participation in the peer review process: is it desirable? Is it implementable? Who are the nonscientists who should become involved? A panel discussion. 
  • Nursing administration research in hospitals and schools of nursing. 
  • Omission of bupropion as a recommended treatment for PTSD. 
  • Overview of registered studies in orthodontics: Evaluation of the ClinicalTrials.gov registry. 
  • Panel discussion 1. 
  • Partnership-driven Resources to Improve and Enhance Research (PRIMER): a survey of community-engaged researchers and creation of an online toolkit. 
  • Patients, physicians, and clinical trials: the other side of the coins. 
  • Perspectives on depression, mild cognitive impairment, and cognitive decline. 
  • Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. 
  • Practice-based research: opportunities and obstacles. 
  • Public access failure at PubMed. 
  • Race disparity in grants: check the citations. 
  • Radiologic sciences research in the next century: new national initiatives and evolving university and industrial relationships. 
  • Reflections 1 year into the 21-Center National Institutes of Health--funded WRIST study: a primer on conducting a multicenter clinical trial. 
  • Relationships between sponsors and investigators in pharmacoeconomic and clinical research. 
  • Report from the biomedical imaging program of the national cancer institute. Status of funding programs. 
  • Representation of women in randomized clinical trials of cardiovascular disease prevention. 
  • Research education and training in otolaryngology: meeting summary and research opportunities. 
  • Research management team (RMT): a model for research support services at Duke University. 
  • Response. 
  • Restore the US lead in biomedical research. 
  • Restoring our health. 
  • Returns to R&D on new drug introductions in the 1980s. 
  • Science and law. View from the bench: patents and material transfers. 
  • Scientists unveil first draft of human genome. 
  • Sex differences in attainment of independent funding by career development awardees. 
  • Support and rewards for scholarly activity in family medicine: a national survey. 
  • Supporting nursing innovations in a cost-conscious environment. 
  • Supporting the Next Generation of Biomedical Researchers. 
  • Surgeons and research: talent, training, time, teachers and teams. 
  • Surgical innovation, industry partnership, and the enemy within. 
  • Task Force 8: Pediatric Cardiology Fellowship Training in Research and Scholarly Activity. SPCTPD/ACC/AAP/AHA. 
  • Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. 
  • The AGING Initiative experience: a call for sustained support for team science networks. 
  • The American Heart Association's 2008 Statement of Principles for Healthcare Reform. 
  • The Lasker Awards--Recognizing and Valuing Investments in Cardiovascular Research. 
  • The case for practical clinical trials in psychiatry. 
  • The changing face of peer review at the National Institutes of Health. 
  • The debt repayment paradox for VA clinical investigators. 
  • The distribution of sales revenues from pharmaceutical innovation. 
  • The economic returns of pediatric clinical trials of antihypertensive drugs. 
  • The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborations. 
  • The need for academic leadership in full-spectrum translational research. 
  • The need for research training in orthopaedic residency education. 
  • The price of innovation: new estimates of drug development costs. 
  • The uncertainty principle and industry-sponsored research. 
  • Tool for planning the grant application process. 
  • Toward protecting the safety of participants in clinical trials. 
  • Transcending marginalization in knowledge development. 
  • Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. 
  • Vision and creation of the American Heart Association pharmaceutical roundtable outcomes research centers. 
  • Watching the WATCH trial: the role of sponsors and data monitoring committees. 
  • What Defines a Valuable Investment in Global Health Research? 
  • What do you do with the "pink sheets?". 
  • What should the Federal government do about Alzheimer's disease? Report of the Secretary's Advisory Panel on Alzheimer's disease. 
  • Who owns the genome? 
  • Why journals should not publish articles funded by the tobacco industry. 
  • Writing successful research proposals for medical science. 
• 

  Keywords of People

  • Brouwer, Rebecca, Dir, Research Initiatives, School of Medicine
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Professor of Urology, Surgery